The colorectal cancer screening market is growing as governments, healthcare providers, and patient organizations focus more on early detection, preventive healthcare, and improved access to cancer-screening services. The market was valued at USD 6.6 billion in 2024 and is projected to reach USD 12 billion by 2035, growing at a CAGR of 5.6%. 1070

Colorectal cancer screening includes fecal immunochemical tests, colonoscopy, CT colonography, stool DNA testing, and related diagnostic methods. These tools help identify potential warning signs, polyps, or cancer-related changes before symptoms become more advanced. Screening recommendations depend on age, risk factors, family history, symptoms, and local clinical guidelines.

Colonoscopy is the largest test segment, valued at USD 3 billion in 2024 and expected to reach USD 5 billion by 2035. It remains important because it can provide direct visualization of the colon and may allow clinicians to remove polyps during the same procedure.

Non-invasive tests are gaining popularity because they can be more convenient and may encourage more people to participate in screening. Fecal immunochemical tests are valued for simplicity, while stool DNA tests are growing quickly because of their convenience and ability to support at-home sample collection.

Homecare settings are becoming more important as patients increasingly prefer privacy and convenience. At-home screening kits, telehealth consultations, and digital reminder programs can help improve participation, especially among people who might otherwise delay screening.

Artificial intelligence is creating opportunities in colonoscopy and imaging workflows. AI-supported systems may help clinicians identify potential abnormalities and improve procedure efficiency. However, professional interpretation and follow-up remain essential.

North America leads the market due to established screening guidelines, health insurance coverage, and strong awareness programs. Asia-Pacific is expected to grow rapidly as cancer awareness, hospital infrastructure, and public-health screening initiatives expand.

Read more: Colorectal Cancer Screening Market

FAQs

Q1. What are the main colorectal cancer screening tests?
They include FIT, colonoscopy, CT colonography, and stool DNA tests.

Q2. Why are non-invasive tests growing in popularity?
They can be more convenient, accessible, and suitable for at-home screening programs.

Tags: colorectal cancer screening, colonoscopy, FIT test, stool DNA test, cancer prevention